Back to results
US 2026/0077129 A1Published application
Ready to use detectors
AssigneeJanssen Biotech, Inc.
InventorsEMMA LOUISE HUBERT, JINGLI WANG, MONICA A. KAPIL, BRANDON MCKENZIE
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeJanssen Biotech, Inc.
InventorsEMMA LOUISE HUBERT, JINGLI WANG, MONICA A. KAPIL, BRANDON MCKENZIE
Estimating the term…
Provided herein are systems and methods for detecting the temperature of and indicating if a pharmaceutical product is ready to be used after a specified amount of time has elapsed. The detectors provided herein are configured to be attached to the pharmaceutical product that contains an active pharmaceutical ingredient (API) therein, and comprise a temperature sensor configured to detect a temperature of the pharmaceutical product; at least one timer configured to start measuring a passage of time if the temperature of the pharmaceutical product detected by the temperature sensor reaches or exceeds a breach temperature; and at least one indicator configured to generate, if a specified amount of time has elapsed on the at least one timer, an indication that the pharmaceutical product is ready to be used.
A detector configured to be attached to a pharmaceutical product that contains an active pharmaceutical ingredient (API) therein, the detector comprising:
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A detector configured to be attached to a pharmaceutical product that contains an active pharmaceutical ingredient (API) therein, the detector comprising:
(canceled)
(canceled)
(canceled)
(canceled)
A liquid crystal sensor configured to be attached to a pharmaceutical product that contains an active pharmaceutical ingredient (API) therein, the liquid crystal sensor comprising:
(canceled)
Dependencies are inferred from the claim text.